
Variantyx: A precision medicine firm using whole genome sequencing for rare genetic disorder diagnosis and oncology treatment optimization.
variantyx.comCrawled Oct 16, 2026
The page describes one test for dual diagnosis.
Variantyx provides resources about its testing process and billing options.
Variantyx provides information about ordering options and whole genome testing for medical practices.
Variantyx has publications about genomic technology and patient diagnosis.
The page features company news, including recently published peer-reviewed articles and press releases.
The company has open positions for professionals on its interdisciplinary team.
IriSight CNV Analysis is a genetic test performed during pregnancy to look for chromosomal conditions in a fetus. It is similar to NIPT/NIPS and chromosomal microarray (CMA) tests.
Variantyx uses whole genome testing in its work on precision medicine.
Variantyx is a molecular diagnostics company offering solutions for genetic disorders, reproductive health, and precision oncology.
Variantyx develops genomic tests to advance precision medicine, improve disease diagnosis, and inform personalized treatment.
Variantyx, Inc.'s contact form requests names, email, phone, ZIP code, audience type, area of interest, and a message. Variantyx, Inc. is listed at 1671 Worcester Road, Suite 400, Framingham, MA 01701, USA.
Variantyx offers whole-genome sequencing diagnostics for rare genetic disorders, reproductive genetics, and precision oncology.
Variantyx collects personal information that people voluntarily provide, including names and email addresses for marketing and company updates. It says it does not collect personal information from website visits unless visitors provide it voluntarily.
GitHubRepository owner